GlassScriptPhysician profile
Sneha Samant
NPI 1770873275
$13,038.43
in general payments reported to CMS, 2019-2025
32 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $550 · 2021: $767 · 2022: $441 · 2023: $1,316 · 2024: $8,159 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $3,921 · Travel and Lodging: $1,317 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $3,921.49 |
| Travel and Lodging | $1,316.66 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,317.33 | 2024 | |
| Glaxosmithkline, LLC. | $1,676.61 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $866.06 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $445.05 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $394.38 | 2019-2025 | Dupixent |
| Genzyme Corporation | $386.22 | 2019-2025 | |
| Grifols USA, LLC | $360.70 | 2020-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $310.68 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Sunovion Pharmaceuticals INC. | $172.73 | 2019-2020 | |
| Mylan Specialty L.P. | $156.04 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $99.67 | 2023-2025 | Winrevair |
| Viatris Specialty LLC | $98.00 | 2025 | Yupelri |
| United Therapeutics Corporation | $97.65 | 2019-2022 | |
| Baxter Healthcare | $76.62 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Ambu INC. | $56.56 | 2022-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $54.32 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Bayer Healthcare Pharmaceuticals INC. | $50.90 | 2021-2023 | |
| Inari Medical, INC. | $49.52 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Nabriva Therapeutics, Plc | $40.50 | 2020-2021 | |
| Verona Pharma, INC. | $39.82 | 2025 | Ohtuvayre |
| Amgen INC. | $38.32 | 2023-2024 | Tezspire |
| Paratek Pharmaceuticals, INC. | $36.93 | 2021-2025 | Nuzyra |
| Insmed, INC. | $32.38 | 2025 | Arikayce, Brinsupri |
| Electromed, INC. | $30.81 | 2024 | Smartvest |
| Pulmonx Corporation | $30.11 | 2024 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Vifor Pharma, INC. | $19.65 | 2025 | Veltassa |
| E.R. Squibb & Sons, L.L.C. | $19.43 | 2024 | Eliquis |
| Resmed Corp | $18.66 | 2019 | |
| Olympus America INC. | $17.74 | 2022 | |
| Pfizer INC. | $16.35 | 2025 | |
| Circassia INC. | $15.17 | 2019 | |
| Philips North America LLC | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sneha Samant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.